Morgan Stanley Issues Key Rating Changes Across MedTech and Healthcare Stocks
Morgan Stanley updates ratings for Inspire Medical, DexCom, and Bausch + Lomb, highlighting slowing growth, improving operations, and strong long-term pipelines.
Morgan Stanley updates ratings for Inspire Medical, DexCom, and Bausch + Lomb, highlighting slowing growth, improving operations, and strong long-term pipelines.
Inspire Medical Systems stock jumps after CMS approves major Medicare payment increase for sleep apnea procedures, effective 2026. Stifel upgrades to Buy.